Skip to content

Study · Not a test of the peptide alone · 2003

2 results

Solution structures of cyclic melanocortin agonists and antagonists by NMR.

Ying J, Kövér KE, Gu X, Han G, Trivedi DB, Kavarana MJ, Hruby VJ

Biopolymers1 Jan 2003Cited by 42 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Melanotan II was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Melanotan II.

  1. 01LabNot a test of Melanotan II aloneIn vitro (cell-free)Mechanism

    By NMR, the cyclic alpha-MSH analogues, including MTII, had similar backbone structures, with beta-turns spanning His6 and D-Phe7 or D-Nal7.

    In plain wordsIn lab tests, MTII and related cyclic peptides showed similar three-dimensional shapes with a turn near the key amino acids.

    Outcome
    Not applicableBackbone structure of cyclic melanocortin analogues including MTII
    Study

    n: not reported in source

    2D NMR in water at pH 4.5 and 25 degrees C
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    beta-Turns spanning His(6) and D-Phe(7)/D-Nal(2')(7) were identified in all analogues, and an amphiphilic molecular surface was obtained for the message sequence residues in most structures within the NMR ensembles.
    1 context sentence
    Summary · context
    The solution structures of the cyclic melanocortin agonists, partial agonist, and antagonists MTII, VJH085, SHU9119, MK5, and MK9 were determined by two-dimensional nuclear magnetic resonance (2D NMR) spectroscopy at pH 4.5 and 25 degrees C in water (90% H(2)O/10% D(2)O).

    In this study, Melanotan II was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Melanotan II.

  2. 02LabNot a test of Melanotan II aloneIn vitro (cell-free)Mechanism

    By NMR, the beta-turn led to stacking between the aromatic rings of His6 and D-Phe7 in MTII and VJH085.

    In plain wordsIn lab tests, two ring-shaped parts of MTII stack against each other.

    Outcome
    Not applicableAromatic stacking between His6 and D-Phe7 in MTII
    Study

    n: not reported in source

    2D NMR in water at pH 4.5 and 25 degrees C
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    The beta-turn, which most closely resembles a type II beta-turn, leads to stacking between the aromatic rings of His(6) and D-Phe(7) in MTII and VJH085.
    1 context sentence
    Summary · context
    The solution structures of the cyclic melanocortin agonists, partial agonist, and antagonists MTII, VJH085, SHU9119, MK5, and MK9 were determined by two-dimensional nuclear magnetic resonance (2D NMR) spectroscopy at pH 4.5 and 25 degrees C in water (90% H(2)O/10% D(2)O).

    In this study, Melanotan II was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Melanotan II.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.